Sterol transporters at membrane contact sites regulate TORC1 and TORC2 signaling

被引:60
|
作者
Murley, Andrew [1 ]
Yamada, Justin [1 ]
Niles, Bradley J. [1 ]
Toulmay, Alexandre [2 ]
Prinz, William A. [2 ]
Powers, Ted [1 ]
Nunnari, Jodi [1 ]
机构
[1] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA
[2] NIDDK, NIH, Bethesda, MD 20892 USA
来源
JOURNAL OF CELL BIOLOGY | 2017年 / 216卷 / 09期
基金
美国国家卫生研究院;
关键词
SACCHAROMYCES-CEREVISIAE; GENE DISRUPTION; KINASE YPK1; PROTEINS; COMPLEX; MICRODOMAINS; CHOLESTEROL; ACTIVATION; MITOCHONDRIA; ORGANIZATION;
D O I
10.1083/jcb.201610032
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Membrane contact sites (MCSs) function to facilitate the formation of membrane domains composed of specialized lipids, proteins, and nucleic acids. In cells, membrane domains regulate membrane dynamics and biochemical and signaling pathways. We and others identified a highly conserved family of sterol transport proteins (Ltc/Lam) localized at diverse MCSs. In this study, we describe data indicating that the yeast family members Ltc1 and Ltc3/4 function at the vacuole and plasma membrane, respectively, to create membrane domains that partition upstream regulators of the TORC1 and TORC2 signaling pathways to coordinate cellular stress responses with sterol homeostasis.
引用
收藏
页码:2679 / 2689
页数:11
相关论文
共 50 条
  • [21] A PP2A-B55-Mediated Crosstalk between TORC1 and TORC2 Regulates the Differentiation Response in Fission Yeast
    Martin, Ruth
    Portantier, Marina
    Chica, Nathalia
    Nyquist-Andersen, Mari
    Mata, Juan
    Lopez-Aviles, Sandra
    [J]. CURRENT BIOLOGY, 2017, 27 (02) : 175 - 188
  • [22] Phase I expansion trial of an oral TORC1/TORC2 inhibitor (CC-223) in advanced solid tumors.
    Varga, Andrea
    Mita, Monica M.
    Wu, Jennifer J.
    Nemunaitis, John J.
    Cloughesy, Timothy Francis
    Mischel, Paul S.
    Bendell, Johanna C.
    Shih, Kent C.
    Paz-Ares, Luis G.
    Mahipal, Amit
    Delord, Jean-Pierre
    Kelley, Robin Katie
    Soria, Jean-Charles
    Wong, Lilly
    Xu, Shuichan
    James, Angela
    Wu, Xiaoling
    Chopra, Rajesh
    Hege, Kristen
    Munster, Pamela N.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [23] Phase I expansion trial of an oral TORC1/TORC2 inhibitor (CC-223) in nonpancreatic neuroendocrine tumors (NET).
    Mita, Monica M.
    Wolin, Edward M.
    Meyer, Tim
    Nemunaitis, John J.
    Bergsland, Emily K.
    Mahipal, Amit
    Wong, Lilly
    Wu, Xiaoling
    Carmichael, James
    Chopra, Rajesh
    Hege, Kristen
    Bendell, Johanna C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [24] PRECLINICAL MODEL OF DUAL-SPECIFIC, MTOR COMPLEX 1 (TORC1) AND MTOR COMPLEX 2 (TORC2) INHIBITORS FOR BLADDER CANCER TREATMENT
    Valera, Vladimir A.
    Konno, Sensuke
    Choudhury, Muhammad
    Phillips, John L.
    [J]. JOURNAL OF UROLOGY, 2016, 195 (04): : E1132 - E1132
  • [25] Phase I trial of an oral TORC1/TORC2 inhibitor (CC-223) in advanced solid and hematologic cancers.
    Shih, Kent C.
    Bendell, Johanna C.
    Reinert, Anne
    Jones, Suzanne
    Kelley, Robin Katie
    Infante, Jeffrey R.
    Korn, Michael
    Hege, Kristen
    Chopra, Rajesh
    Xu, Shuichan
    Wong, Lilly
    Liu, Yong
    Mortensen, Deborah
    Munster, Pamela N.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [26] Establishing spatial control over TORC1 signaling
    Schmidt, Oliver
    de Araujo, Mariana E. G.
    [J]. JOURNAL OF CELL BIOLOGY, 2022, 221 (05):
  • [27] Nitrogen Regulates AMPK to Control TORC1 Signaling
    Davie, Elizabeth
    Forte, Gabriella M. A.
    Petersen, Janni
    [J]. CURRENT BIOLOGY, 2015, 25 (04) : 445 - 454
  • [28] Feedback regulation of TORC1 signaling in fission yeast
    Ma, N.
    Liu, Q.
    Zhang, L.
    Qi, Y.
    Ma, Y.
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2013, 24
  • [29] Phase 1 Expansion Study of an Oral TORC1/TORC2 Inhibitor (CC-223) in Non-Pancreatic Neuroendocrine Tumors (NET)
    Wolin, Edward
    Mita, Monica
    Meyer, Tim
    Bendell, Johanna
    Mahipal, Amit
    Nemunaitis, John
    Munster, Pam
    Paz-Arez, Luis
    Hull, Wayne
    James, Angela
    Trowe, Torsten
    Swaminathan, Mahesh
    Wu, Xiaoling
    de Haan, Hans
    [J]. PANCREAS, 2015, 44 (02) : 362 - 362
  • [30] Phase 1 Expansion Study of an Oral TORC1/TORC2 Inhibitor (CC-223) in Non-Pancreatic Neuroendocrine Tumors (NET)
    Wolin, Edward
    Mita, Monica
    Meyer, Tim
    Bendell, Johanna
    Mahipal, Amit
    Nemunaitis, John
    Wong, Lilly
    Wu, Xiaoling
    Carmichael, James
    Chopra, Rajesh
    Hege, Kristen
    [J]. PANCREAS, 2014, 43 (03) : 508 - 508